Format

Send to

Choose Destination
Interact Cardiovasc Thorac Surg. 2017 Feb 1;24(2):188-195. doi: 10.1093/icvts/ivw326.

Detection of intraoperative myocardial dysfunction by accelerometer during aortic valve replacement.

Author information

1
The Intervention Centre, Oslo University Hospital, Oslo, Norway.
2
Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
3
Department of Anaesthesiology, Oslo University Hospital, Oslo, Norway.
4
Department of Cardiology, Oslo University Hospital, Oslo, Norway.
5
Department of Cardiothoracic Surgery, Oslo University Hospital, Oslo, Norway.
6
Department of Cardiology, Akershus University Hospital, Lørenskog, Norway.

Abstract

OBJECTIVES:

Myocardial dysfunction may occur during weaning from cardiopulmonary bypass (CPB). Epicardial accelerometers have been shown to be useful in continuous monitoring of myocardial ischaemia during beating-heart surgery. We aimed to investigate whether an accelerometer can detect myocardial dysfunction during weaning from CPB.

METHODS:

In 23 patients undergoing isolated aortic valve replacement (AVR), a three-axis accelerometer was attached to the left ventricle and 3D velocity was calculated from the signals. Peak early systolic velocity (Vsys) and velocity at aortic valve closure (Vavc) were measured. Measurements were undertaken during normothermia with 50% bypass flow and atrial pacing (90 beats/min) before aortic cross-clamping and after cross-clamp removal. Myocardial dysfunction was defined as Vsys < Vavc, and patients were classified as having normal function or dysfunction. Left ventricular (LV) stroke work via pulmonary artery catheter and systolic velocity by echocardiography were compared between groups and used as reference methods.

RESULTS:

The accelerometer identified a substantial proportion of patients with myocardial dysfunction during weaning from CPB, 56% of patients compared with 11% before aortic cross-clamping. Patients classified with normal myocardial function during weaning significantly improved their LV stroke work and systolic velocity by echocardiography in response to AVR, whereas those classified with dysfunction did not. Accelerometer classification of normal function predicted an increase in echocardiographic systolic velocity [r = 0.63, regression coefficient 1.98, 95% CI (0.57, 3.40) (P < 0.01)].

CONCLUSIONS:

The accelerometer detected myocardial dysfunction during weaning from CPB in accordance with measures obtained by echocardiography and pulmonary artery catheter.

Clinical Trials identifier:

NCT01926067. https://clinicaltrials.gov/.

KEYWORDS:

Aortic valve replacement; Cardiac monitoring; Left ventricular function; Motion sensor

PMID:
28364479
DOI:
10.1093/icvts/ivw326
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Silverchair Information Systems Icon for Norwegian BIBSYS system
Loading ...
Support Center